Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT00572234
Eligibility Criteria:
Inclusion Criteria:
* patient in the substance use disorder program at either the Omaha VA Medical Center or at Catholic Charities Campus for Hope
* diagnosis of methamphetamine dependence as well as presence or history of psychosis based on the Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria (not to include patients in full sustained remission)
* provide names, addresses, and phone numbers of at least two collateral informants who can provide information on their methamphetamine and other drug use during follow-up
* must sign an informed consent as approved by the UNMC Internal Review Board (IRB) and Catholic Charities Research Committee.
Exclusion Criteria:
* a history of severe injury to their brain
* advanced cardiac, pulmonary, renal or liver disease
* predisposition to seizures
* history of bulimia or anorexia nervosa
* current diagnosis of major depressive disorder
* diagnosis or past history of panic disorders, schizophrenia, or bipolar affective disorder
* family history or childhood history of epilepsy or seizures
* history of strokes, brain tumors, or bleeding in the brain.
* used any psychoactive drug within one week of study entry (two weeks for MAO (monoamine oxidase) inhibitors or protriptyline, four weeks for fluoxetine)
* currently using any theophylline product (e.g. Theodur)
* used an investigational drug in any study within the past four weeks
* used a therapeutic course of bupropion SR for \> 1 week at any time in the past 12 months or have been evaluated in previous studies examining bupropion SR at anytime
* If female, the participant must not be pregnant or breast feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT00572234
Study Brief:
Protocol Section:
NCT00572234